Compound Detail
CHEMBL225072
PEMETREXED 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Nc1nc2[nH]cc(CCc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)c2c(=O)[nH]1
Basic Information
| ChEMBL ID | CHEMBL225072 |
| Name | PEMETREXED |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | WBXPDJSOTKVWSJ-ZDUSSCGKSA-N |
| Therapeutic | ✓ Yes |
40
Targets
255
Activities
3
Assay Types
3
PK Parameters
20
Publications
6
Known Names
20
Indications
3
Mechanisms
Molecular Properties
427.4
MW (Da)
0.67
ALogP
6
HBA
6
HBD
191.3
PSA (Ų)
0.29
QED
1
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2004 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dihydrofolate reductase inhibitor | INHIBITOR | Dihydrofolate reductase | ✓ | ✓ |
| Thymidylate synthase inhibitor | INHIBITOR | Thymidylate synthase | ✓ | ✓ |
| GAR transformylase inhibitor | INHIBITOR | Trifunctional purine biosynthetic protein adenosine-3 | ✓ | ✓ |
Indications
Mesothelioma Mesothelioma Mesothelioma Neoplasms Neoplasms Adenocarcinoma of Lung Carcinoma Carcinoma, Non-Small-Cell Lung Head and Neck Neoplasms Head and Neck Neoplasms Lung Neoplasms Lung Neoplasms Small Cell Lung Carcinoma Stomach Neoplasms Stomach Neoplasms Stomach Neoplasms Uterine Cervical Neoplasms Uterine Cervical Neoplasms Adenocarcinoma Biliary Tract Neoplasms
ATC Classification
L01BA04
pemetrexed
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
IC50 229 meas. best 8.31
Ki 25 meas. best 8.89
Kd 1 meas. best 4.77
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Thymidylate synthase CHEMBL1952 | Ki | 8.89 | 8.0833 | 1.3 | 3 |
| R2 CHEMBL614385 | IC50 | 8.31 | 7.0289 | 4.9 | 9 |
| Dihydrofolate reductase CHEMBL202 | Ki | 8.15 | 8.1433 | 7.0 | 3 |
| Proton-coupled folate transporter CHEMBL1795188 | IC50 | 8.08 | 7.778 | 8.3 | 5 |
| KB CHEMBL398 | IC50 | 8.0 | 7.015 | 9.9 | 18 |
| Unchecked CHEMBL612545 | IC50 | 7.93 | 6.2124 | 11.7 | 25 |
| Trifunctional purine biosynthetic protein adenosine-3 CHEMBL3972 | IC50 | 7.93 | 7.6275 | 11.7 | 4 |
| CHO CHEMBL613853 | IC50 | 7.88 | 7.078 | 13.2 | 5 |
| CCRF-CEM CHEMBL382 | IC50 | 7.8 | 7.8 | 16.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 7.74 | 6.985 | 18.2 | 18 |
| L1210 CHEMBL386 | IC50 | 7.66 | 7.66 | 22.0 | 1 |
| IGROV-1 CHEMBL613984 | IC50 | 7.65 | 7.0711 | 22.2 | 9 |
| Reduced folate transporter CHEMBL4833 | IC50 | 7.62 | 7.156 | 23.8 | 5 |
| A2780 CHEMBL614004 | IC50 | 7.41 | 7.41 | 39.4 | 1 |
| Folate receptor alpha CHEMBL2121 | IC50 | 7.38 | 6.9967 | 42.0 | 6 |
| Folate receptor beta CHEMBL5064 | IC50 | 7.22 | 6.8167 | 60.0 | 6 |
| Trifunctional purine biosynthetic protein adenosine-3 CHEMBL3972 | Ki | 7.19 | 6.178 | 65.0 | 5 |
| Dihydrofolate reductase CHEMBL202 | IC50 | 7.17 | 5.5112 | 68.0 | 17 |
| Thymidylate synthase/GAR transformylase/AICAR transformylase CHEMBL3885528 | IC50 | 7.16 | 7.16 | 70.0 | 1 |
| A549 CHEMBL392 | IC50 | 7.1 | 6.012 | 80.0 | 5 |
| SW-620 CHEMBL612262 | IC50 | 7.1 | 7.075 | 80.2 | 2 |
| Proton-coupled folate transporter CHEMBL1795188 | Ki | 7.03 | 6.57 | 94.0 | 7 |
| Thymidylate synthase CHEMBL1952 | IC50 | 6.69 | 5.0318 | 204.0 | 22 |
| Thymidylate synthase CHEMBL3160 | Ki | 6.47 | 6.47 | 340.0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase CHEMBL2425 | IC50 | 6.37 | 5.8513 | 430.0 | 15 |
| Thymidylate synthase CHEMBL5328 | Ki | 6.26 | 6.26 | 550.0 | 1 |
| Dihydrofolate reductase CHEMBL4564 | Ki | 6.25 | 6.25 | 560.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 6.19 | 6.19 | 650.0 | 1 |
| Bifunctional purine biosynthesis protein ATIC CHEMBL2518 | Ki | 6.06 | 6.06 | 880.0 | 1 |
| ADMET CHEMBL612558 | IC50 | 6.05 | 6.02 | 894.0 | 4 |
| Thymidylate synthase CHEMBL6137 | IC50 | 5.96 | 4.364 | 1100.0 | 10 |
| HepG2 CHEMBL395 | IC50 | 5.9 | 5.9 | 1260.0 | 1 |
| HUVEC CHEMBL613979 | IC50 | 5.76 | 5.76 | 1730.0 | 1 |
| NCI-H1975 CHEMBL614348 | IC50 | 5.67 | 5.67 | 2130.0 | 1 |
| Dihydrofolate reductase CHEMBL1809 | IC50 | 5.64 | 5.64 | 2300.0 | 1 |
| Dihydrofolate reductase CHEMBL2902 | IC50 | 5.64 | 5.64 | 2300.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 5.42 | 5.42 | 3850.0 | 1 |
| Calu-1 CHEMBL613505 | IC50 | 5.29 | 5.29 | 5120.0 | 1 |
| OVCAR-3 CHEMBL614213 | IC50 | 5.16 | 5.16 | 6900.0 | 1 |
| SGC-7901 CHEMBL614909 | IC50 | 5.04 | 5.04 | 9080.0 | 1 |
| Thymidylate synthase CHEMBL2555 | IC50 | 4.82 | 4.82 | 15000.0 | 1 |
| Serine hydroxymethyltransferase, cytosolic CHEMBL1772927 | Kd | 4.77 | 4.77 | 16900.0 | 1 |
| Serine hydroxymethyltransferase, cytosolic CHEMBL1772927 | Ki | 4.72 | 4.6 | 19100.0 | 2 |
| Thymidylate synthase CHEMBL5328 | IC50 | 4.7 | 4.56 | 20000.0 | 4 |
| Thymidylate synthase CHEMBL4341 | IC50 | 4.7 | 4.7 | 20000.0 | 1 |
| Thymidylate synthase (EC 2.1.1.45) (TS) (TSase) CHEMBL1795153 | IC50 | 4.12 | 4.12 | 76000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 0.01104 | mL.min-1.g-1 | Mus musculus |
| T1/2 | 0.65 | hr | Mus musculus |
| Vd | 0.62 | ml | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine